NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023
Journal of the National Comprehensive Cancer Network · 2023-07 · 21 (7) · 694-704
DOI: 10.6004/jnccn.2023.0035 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2023-07. Verfasst von Al B Benson und 40 weiteren Autor:innen. Beteiligte Einrichtung: Robert H. Lurie Comprehensive Cancer Center of Northwestern University. Hauptthemen laut MEDLINE: Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma, Liver Neoplasms. Die Arbeit wurde bisher 213-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
In 2023, the NCCN Guidelines for Hepatobiliary Cancers were divided into 2 separate guidelines: Hepatocellular Carcinoma and Biliary Tract Cancers. The NCCN Guidelines for Biliary Tract Cancers provide recommendations for the evaluation and comprehensive care of patients with gallbladder cancer, intrahepatic cholangiocarcinoma, and extrahepatic cholangiocarcinoma. The multidisciplinary panel of experts meets at least on an annual basis to review requests from internal and external entities as well as to evaluate new data on current and emerging therapies. These Guidelines Insights focus on some of the recent updates to the NCCN Guidelines for Biliary Tract Cancers as well as the newly published section on principles of molecular testing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
- Memorial Sloan Kettering Cancer Center.
- Dana-Farber/Brigham and Women's Cancer Center.
- University of Wisconsin Carbone Cancer Center.
- Stanford Cancer Institute.
- Moffitt Cancer Center.
Zitieren
APA
Benson, A. B., D'Angelica, M. I., Abrams, T., Abbott, D. E., Ahmed, A., Anaya, D. A., Anders, R., Are, C., Bachini, M., Binder, D., Borad, M., Bowlus, C., Brown, D., Burgoyne, A., Castellanos, J., Chahal, P., Cloyd, J., Covey, A. M., Glazer, E. S., …, & Hochstetler, C. (2023). NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023. Journal of the National Comprehensive Cancer Network, 21(7), 694-704. https://doi.org/10.6004/jnccn.2023.0035
Vancouver
Benson AB, D'Angelica MI, Abrams T, Abbott DE, Ahmed A, Anaya DA, et al. NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023. Journal of the National Comprehensive Cancer Network. 2023;21(7):694-704. doi:10.6004/jnccn.2023.0035
BibTeX
@article{Benson2023,
author = {Benson, Al B and D'Angelica, Michael I and Abrams, Thomas and Abbott, Daniel E and Ahmed, Aijaz and Anaya, Daniel A and Anders, Robert and Are, Chandrakanth and Bachini, Melinda and Binder, David and Borad, Mitesh and Bowlus, Christopher and Brown, Daniel and Burgoyne, Adam and Castellanos, Jason and Chahal, Prabhleen and Cloyd, Jordan and Covey, Anne M and Glazer, Evan S and Hawkins, William G and Iyer, Renuka and Jacob, Rojymon and Jennings, Lawrence and Kelley, R Kate and Kim, Robin and Levine, Matthew and Palta, Manisha and Park, James O and Raman, Steven and Reddy, Sanjay and Ronnekleiv-Kelly, Sean and Sahai, Vaibhav and Singh, Gagandeep and Stein, Stacey and Turk, Anita and Vauthey, Jean-Nicolas and Venook, Alan P and Yopp, Adam and McMillian, Nicole and Schonfeld, Ryan and Hochstetler, Cindy},
title = {NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023},
journal = {Journal of the National Comprehensive Cancer Network},
year = {2023},
volume = {21},
number = {7},
pages = {694--704},
doi = {10.6004/jnccn.2023.0035}
}
EUVIMED